FDA Approves Osimertinib for Unresectable NSCLC

Approval follows priority review granted based on findings from the LAURA trial.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-okays-osimertinib-after-crt-locally-advanced-2024a1000hjd?src=rss